FTC Secures $12M Settlement Over Edwards-JC Medical Deal
By Jared Foretek · July 13, 2026, 7:34 PM EDT
California-based Edwards Lifesciences and Singapore's Genesis Medtech agreed to pay a combined $12 million to settle claims from the Federal Trade Commission that Edwards attempted to evade the Hart-Scott-Rodino notification and...
To view the full article, register now.